Agenda

ATMP Sweden 2026 brings academia, healthcare and industry together around a single question: what needs to change for advanced therapies to reach patients at scale?

Over two days the programme covers emerging science from Swedish and Nordic research groups, regulatory and manufacturing routes that carry it toward the clinic, the trial infrastructure and capability that puts it in front of patients, and the funding and reimbursement models that decide whether it stays there. Throughout it all are the translational journeys behind the field, successes and failures alike, and the patient voices that gives the work purpose.

Time	Day 1 – Tuesday 1 December, 8:00-18:00	Topic	Chairs & Co-Chairs	Speakers
8:00	Venue Opening & Registration
8:45	Opening Adress
9:00	Session 1 Plenary:	From Breakthrough Science to Patient Impact	Matti Sällberg, Karolinska Institute Eva-Karin Gidlund, NorthX Biologics	Di Yu, Uppsala University, Elicera Therapeutics AB Xiaoqin Wang, AstraZeneca Mark Farmery, Anocca AB
10:00	Break
10:30	Session 1 Plenary (Continued):	From Breakthrough Science to Patient Impact		Andrea Salmén, NeoGap Therapeutics AB Hans Preusting, Mendus Knut Steffensen, Karolinska ATMP Center
11:30	Lunch
12:15	Sponsor Session	To be announced		CCRM Nordic
13:00	Session 2:	Regulatory Pathways and Accelerated Development in the Nordics and EU	Anna Koptina Gültekin, AI4RA Björn Carlsson, SSI Strategy	Stine Kihl-Plambek, ATMP Denmark Martin Bronislaw Oleksiewicz, DMA & Danish EMA CAT Anna Koptina Gültekin, AI4RA Björn Carlsson, SSI Strategy
14:00	Break
14:30	Session 2 (Continued):	Regulatory Pathways and Accelerated Development in the Nordics and EU		Alessandro Aiuti, San Raffaele Telethon Institute Panel Discussion: Stine Kihl-Plambek, Martin Bronislaw Oleksiewicz, Alessandro Aiuti Patrick Ginty, VectusBio Consulting
15:30	Session 3:	Frontiers in ATMP Discovery and Innovation + Poster Session	Pierfrancesco Pagella, Linköping University Mattias Magnusson, Lund University Johan Flygare, Lund University Fredrik Lanner, Karolinska Institutet Anna Pasetto, Oslo University Hospital	Malin Parmar, Lund University Selected abstract presentations
16:00	Break
16:30	Session 3 (Continued):	Frontiers in ATMP Discovery and Innovation		Selected abstract presentations Karl Johan Malmberg, Karolinska Institutet
18:00-Late	After Work + Poster Session

Time	Day 2 – Wednesday 2 December, 8:30-18:30	Topic	Chairs & Co-Chairs	Speakers
8:30	Venue Opening & Registration
9:00	Session 4:	Clinical Advancement and Challenges in ATMP for the Brain	Mats Hellström, Uppsala University Hjalmar Bjartmarz, Skåne University Hospital	Xiuming Liang, Karolinska Institute Mats Hellström, Uppsala University Hjalmar Bjartmarz, Skåne University Hospital
10:00	Break
10:30	Session 4 (Continued):	Clinical Advancement and Challenges in ATMP for the Brain		Fredrik Swartling, Uppsala University More speakers to be confirmed
11:30	Lunch & Mingle
13:00	Session 5:	From Price Tags to Payment Pathways	Dag Larsson, Lif Jim Lund, CCRM Nordic Magdalena Bengtsson Levin, Johnson & Johnson	Francis Pang, Orchard Tx More speakers to be confirmed
14:00	Break
14:30	Session 5 (Continued):	From Price Tags to Payment Pathways		More speakers to be confirmed
15:30	Session 6:	Clinical Translation / Innovation Network and the Patient Impact	Hannah Karlsson, ATMP Uppsala, CGT Sweden NACNET Helena Luning, SweTrial	Hannah Karlsson, ATMP Uppsala, CGT Sweden NACNET Antonia Mueller, Medical University of Vienna Panel Discussion
16:00	Break
16:30	Session 6 (Continued):	Clinical Translation / Innovation Network and the Patient Impact		Kristina Kannisto, SweTrial Karl-Henrik Grinnemo, AVulotion AB Natasha Bank, ATMP Flemingsberg
18:00	Closing Adress

The agenda is still taking shape – session names, timing, and other details are subject to change.